In fact, in these cells miR-18b expression is frequently downmodulated by hypermethylation; MDM2 is a molecular target of miR-18b, and the downmodulation of this miR in melanoma cells is responsible for MDM2 upmodulation, with consequent p53 inactivation [84]. This evidence concerns the gene MDM2 and melanoma.